Cart
sales@molnova.com
Dazcapistat
CAS No. 2221010-42-8
Dazcapistat( —— )
Catalog No. M28849 CAS No. 2221010-42-8
Dazcapistat is a potent calpain inhibitor, with IC50s of <3 μM for calpain 1, calpain 2 and calpain 9, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 237 | Get Quote |
|
| 10MG | 385 | Get Quote |
|
| 25MG | 644 | Get Quote |
|
| 50MG | 888 | Get Quote |
|
| 100MG | 1233 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDazcapistat
-
NoteResearch use only, not for human use.
-
Brief DescriptionDazcapistat is a potent calpain inhibitor, with IC50s of <3 μM for calpain 1, calpain 2 and calpain 9, respectively.
-
DescriptionDazcapistat is a potent calpain inhibitor, with IC50s of <3 μM for calpain 1, calpain 2 and calpain 9, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetCysteine Protease
-
Recptornecrosis(MLKL)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2221010-42-8
-
Formula Weight395.39
-
Molecular FormulaC21H18FN3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (252.92 mM)
-
SMILESO=C(C1=C(C2=CC=CC=C2F)N=C(C)O1)NC(C(C(N)=O)=O)CC3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dodo K, et al. Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury. ACS Med Chem Lett. 2018 Jan 29;9(3):182-187.
molnova catalog
related products
-
(1S,2R)-Alicapistat
(1S,2R)-Alicapistat ((1S,2R)-ABT-957) is a highly efficient, orally active compound that selectively inhibits human calpains 1 and 2, showing promise for Alzheimer's disease (AD) therapy .
-
Z-Lys-OH
Z-Lys-OH is a competitive inhibitor of papain, a lysine derivative.
-
Cysteine protease in...
Cysteine protease inhibitor 2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor 2 inhibited DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
